Clinical Trial Update: Efficacy and Safety of Ilaprazole Based Bismuth-containing Quadruple Regimen for the First-line Treatment of Helicobacter Pylori Infection [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the efficacy and safety of an ilaprazole-based, bismuth-containing quadruple regimen as first-line treatment for Helicobacter pylori inf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Ilaprazole (ilaprazole)

Snippet

Sponsor: Livzon Pharmaceutical Group Inc. | Conditions: Helicobacter Pylori Eradication Antibiotic | Phase 4 | Status: COMPLETED